Large-scale deep learning analysis to identify adult patients at risk for combined and common variable

Giorgos Papanastasiou1, Guang Yang2,3,4, Dimitris I Fotiadis5,6

  • 1Pfizer Inc, New York, NY, USA. georgios.papanastasiou@pfizer.com.

Communications Medicine
|December 20, 2023
PubMed
Abstract